Management of moderate to severe chronic low back pain with buprenorphine buccal film using novel bioerodible mucoadhesive technology

With a global prevalence of ~9%–12%, low back pain (LBP) is a serious public health issue, associated with high costs for treatment and lost productivity. Chronic LBP (cLBP) involves central sensitization, a neuropathic pain component, and may induce maladaptive coping strategies and depression. Tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Pergolizzi, Joseph V, Raffa, Robert B, Fleischer, Charles, Zampogna, Gianpietro, Taylor, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096757/
https://www.ncbi.nlm.nih.gov/pubmed/27826213
http://dx.doi.org/10.2147/JPR.S87952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096757/
https://www.ncbi.nlm.nih.gov/pubmed/27826213
http://dx.doi.org/10.2147/JPR.S87952

Ejemplares similares